Initiation of DNA replication requires the action of the Dbf4/Cdc7 kinase complex (DDK) which is also a phosphorylation target of Rad53 kinase in the S-phase checkpoint. DDK is thought to trigger DNA replication by phosphorylating members of the Mcm2-7 complex present at origins of replication. While DDK phosphorylation sites have been identified on Mcm2-7, the contributions made by Dbf4 and Cdc7 to the targeting of the complex have not been established. DDK has also been implicated in the S-phase checkpoint response since it is removed from chromatin in a Rad53-dependent manner. The interaction of Dbf4 and Cdc7 with each of the Mcm2-7 subunits was assessed and showed an interaction between Dbf4 and Mcm2 and Mcm6, while interactions between Cdc7 and Mcm4 and Mcm5 were observed. Mutations in Mcm2 and Mcm4 that disrupt the interactions with Dbf4 or Cdc7 showed modest growth impairment and compromised DNA replication, while simultaneous abrogation of both interactions resulted in lethality. Strains overexpressing Mcm2 or Mcm4 were sensitive to genotoxic agents, while overexpression of Mcm2 in a Mcm4Δ175-333 strain background resulted in a severe growth impairment as well as sensitivity to genotoxic stress. ChIP analysis revealed the possibility of Dbf4/Cdc7 localization to origin flanking regions through most of S-phase, which may redistribute to origins at the time of firing. Fluorescence microscopy of Mcm2 and Dbf4 in S-phase seem to show a punctate pattern of staining, consistent with these factors’ localization to ‘replication factories.’ By using a Dbf4ΔN mutant, the N-motif was shown to be required for the Rad53-mediated removal of Dbf4 from chromatin under checkpoint conditions. Initial optimization of a DNA combing protocol was also performed, which along with Dbf4ΔN mutant and the fluorescently-epitope tagged strains, will be useful tools for evaluating a role for DDK in the S-phase checkpoint response. Altered levels of DNA replication factors have been implicated in many human cancers. The data presented in this study provide novel insight into the normal process of the initiation of DNA replication which can be applied to research involving higher eukaryotes, including humans, and can serve as a benchmark for comparison with the cancer phenotype.

From microscopic bacteria to the giant whale, every single living organism on Earth uses the same language of life: DNA. Deoxyribonucleoside triphosphates––dNTPs (dATP, dTTP, dGTP, and dCTP)––are the building blocks of DNA and are therefore the “alphabet of life”. A balanced supply of dNTPs is essential for integral DNA transactions such as faithful genome duplication and repair. The enzyme ribonucleotide reductase (RNR) not only synthesizes all four dNTPs but also primarily maintains the crucial individual concentration of each dNTP in a cell. In this thesis we investigated what happens if the crucial balanced supply of dNTPs is disrupted, addressing whether a cell has a mechanism to detect imbalanced dNTP pools and whether all pool imbalances are equally mutagenic. To address these questions, we introduced single amino acid substitutions into loop 2 of the allosteric specificity site of Saccharomyces cerevisiae RNR and obtained a collection of yeast strains with different but defined dNTP pool imbalances. These results directly confirmed that the loop 2 is the structural link between the substrate specificity and effector binding sites of RNR. We were surprised to observe that mutagenesis was enhanced even in a strain with mildly imbalanced dNTP pools, despite the availability of the two major replication error correction mechanisms: proofreading and mismatch repair. However, the mutagenic potential of different dNTP pool imbalances did not directly correlate with their severity, and the locations of the mutations in a strain with elevated dTTP and dCTP were completely different from those in a strain with elevated dATP and dGTP. We then investigated, whether dNTP pool imbalances interfere with cell cycle progression and if they are detected by the S-phase checkpoint, a genome surveillance mechanism activated in response to DNA damage or replication blocks. The S-phase checkpoint was activated by the depletion of one or more dNTPs. In contrast, when none of the dNTP pools was limiting for DNA replication, even extreme and mutagenic dNTP pool imbalances did not activate the S-phase checkpoint and did not interfere with the cell cycle progression. We also observed an interesting mutational strand bias in one of the mutant rnr1 strains suggesting that the S-phase checkpoint may selectively prevent formation of replication errors during leading strand replication. We further used these strains to study the mechanisms by which dNTP pool imbalances induce genome instability. In addition, we discovered that a high dNTP concentration allows replicative DNA polymerases to bypass certain DNA lesions, which are difficult to bypass at normal dNTP concentrations. Our results broaden the role of dNTPs beyond ‘dNTPs as the building blocks’ and suggest that dNTPs are not only the building blocks of DNA but also that their concentrations in a cell have regulatory implications for maintaining genomic integrity. This is important as all cancers arise as a result of some kind of genomic abnormality.

Initiation of DNA replication requires the action of the Dbf4/Cdc7 kinase complex (DDK) which is also a phosphorylation target of Rad53 kinase in the S-phase checkpoint. DDK is thought to trigger DNA replication by phosphorylating members of the Mcm2-7 complex present at origins of replication. While DDK phosphorylation sites have been identified on Mcm2-7, the contributions made by Dbf4 and Cdc7 to the targeting of the complex have not been established. DDK has also been implicated in the S-phase checkpoint response since it is removed from chromatin in a Rad53-dependent manner. The interaction of Dbf4 and Cdc7 with each of the Mcm2-7 subunits was assessed and showed an interaction between Dbf4 and Mcm2 and Mcm6, while interactions between Cdc7 and Mcm4 and Mcm5 were observed. Mutations in Mcm2 and Mcm4 that disrupt the interactions with Dbf4 or Cdc7 showed modest growth impairment and compromised DNA replication, while simultaneous abrogation of both interactions resulted in lethality. Strains overexpressing Mcm2 or Mcm4 were sensitive to genotoxic agents, while overexpression of Mcm2 in a Mcm4Δ175-333 strain background resulted in a severe growth impairment as well as sensitivity to genotoxic stress. ChIP analysis revealed the possibility of Dbf4/Cdc7 localization to origin flanking regions through most of S-phase, which may redistribute to origins at the time of firing. Fluorescence microscopy of Mcm2 and Dbf4 in S-phase seem to show a punctate pattern of staining, consistent with these factors’ localization to ‘replication factories.’ By using a Dbf4ΔN mutant, the N-motif was shown to be required for the Rad53-mediated removal of Dbf4 from chromatin under checkpoint conditions. Initial optimization of a DNA combing protocol was also performed, which along with Dbf4ΔN mutant and the fluorescently-epitope tagged strains, will be useful tools for evaluating a role for DDK in the S-phase checkpoint response. Altered levels of DNA replication factors have been implicated in many human cancers. The data presented in this study provide novel insight into the normal process of the initiation of DNA replication which can be applied to research involving higher eukaryotes, including humans, and can serve as a benchmark for comparison with the cancer phenotype.

The essential cell cycle kinase Dbf4/Cdc7 (DDK) triggers DNA replication through phosphorylation of the Mcm2-7 helicase at replication origins. Prior work has implicated various Mcm2-7 subunits as targets of DDK, however it is not well understood which specific subunits mediate the docking of the DDK complex. Through yeast two-hybrid and co-immunoprecipitation analyses, we found that Dbf4 and Cdc7 interact with distinct subunits of the Mcm2-7 helicase complex. Dbf4 showed the strongest interaction with Mcm2 while Cdc7 associated with Mcm4 and Mcm5. Dissection of the N-terminal region of Mcm2 revealed two regions that mediate the interaction with Dbf4, whereas in Mcm4, a region near the N-terminus has been previously identified by another group as the DDK docking domain. Mutant forms of Mcm2 (Mcm2ΔDDD) or Mcm4 (Mcm4ΔDDD) lacking the DDK docking domain were expressed in cells and resulted in modest growth and replication defects. Combining the two mutations resulted in synthetic lethality, suggesting a redundant mechanism of Mcm2 and Mcm4 in targeting the DDK complex to Mcm rings. Furthermore, growth inhibition could be induced in a Mcm4ΔDDD background by overexpressing Mcm2 to titrate Dbf4 from Mcm rings. These growth defects were exacerbated in the presence of genotoxic agents such as hydroxyurea and methyl methanesulfonate, suggesting that DDK-Mcm interactions may play a role in stabilizing replication forks under S-phase checkpoint conditions. Regions of Cdc7 were examined for their interaction with Mcm4 and Dbf4. Results have shown that the N-terminal amino acid region 55-124 and the C-terminal region 453-507 of Cdc7 are likely target regions for Dbf4-binding. Several conserved residues were identified within the N-terminal 55-124 Cdc7 region that interface with conserved residues within motif-C of Dbf4. Conserved residues were identified within the DDD domain of Mcm2 and mutating these residues resulted in a decreased interaction with Dbf4. Lastly, bioinformatics analysis has revealed potential conserved residues within the Mcm4DDD region, which may play a role in binding to Cdc7. This research is significant because these factors, which are conserved in all eukaryotes studied to date, should give further insight as to how DNA replication is triggered and how it is affected when cells are exposed to DNA damaging or replication compromising agents. This research also has implications in cancer genetics, as prior studies have shown elevated DDK and Mcm protein levels in tumour cell lines and melanomas, with Cdc7 showing great promise as a cancer therapeutic target. Such knowledge will further enhance our understanding of the DNA replication process and the roles of cell cycle proteins involved, under both normal and checkpoint conditions.

La réplication de l'ADN est un évènement majeur pour la cellule car elle permet la duplication fidèle du matériel génétique. Il s'agit d'une étape critique du cycle cellulaire, car les fourches de réplication rencontrent fréquemment des barrières naturelles ou des lésions d'origine endogènes (lésions oxydatives) ou exogènes (agents physiques ou chimiques), sources de cassures chromosomiques et donc d'instabilité génétique. Une des réponses à ces fourches bloquées est l'activation du point de contrôle (checkpoint) de la phase S du cycle cellulaire. Nous avons montré que l'ADN polymérase Kappa (pol Kappa), polymérase dite translesionnelle en raison de ses capacité à franchir des lésions sur l'ADN, s'avère être aussi un acteur du point de contrôle de phase S. En effet, la déplétion de pol Kappa par ARN interférence dans différentes lignées cellulaires ou par immunodépletion d'un extrait de Xénope, entraîne un défaut de phosphorylation de Chk1. Pol Kappa est impliquée dans la synthèse de brins naissant d'ADN au niveau des fourches bloquées, ce qui facilite le recrutement du complexe 9-1-1 composé des protéines Rad9, Rad1 et Hus1et permet alors, une activation correcte du checkpoint de phase S. Afin de décrypter le rôle de pol kappa, nous avons construits différents mutants et nous avons analysé leur capacité à former des foyers, à être recrutés à la chromatine et à interagir avec différents partenaires dans des conditions d'activation du point de contrôle de phase S. Nous avons pu constater que le mutant du domaine d'interaction à PCNA était incapable de former des foci foyers ?. Nous avons ensuite observé, qu'en condition de stress réplicatif, pol Kappa était recruté à la chromatine grâce à son domaine d'interaction à PCNA et par différentes approches biochimiques, nous avons pu voir que pol kappa interagissait avec Rad9 et Chk1. Nous avons également mis en évidence que le défaut d'activation de Chk1 en l'absence de pol kappa reflétait d'une diminution de son taux dans le noyau, suggérant une régulation commune entre Chk1 et pol Kappa. En effet, nous avons observé que pol Kappa, comme Chk1, était régulés par l'ubiquitine hydrolase USP7. En effet, l'interaction entre pol Kappa et USP7 est augmentée en condition de stress. Nous avons pu voir, qu'à l'instar de Chk1, l'absence de USP7 entrainait une baisse du niveau de pol kappa dans le noyau. Ainsi nous proposons qu'en réponse à un stress réplicatif, pol Kappa et Chk1 soient stabilisés via leur dé-ubiquitination par USP7, permettant leur recrutement à la chromatine et une activation correcte du checkpoint de phase S. Parallèlement à ces travaux, des publications récentes montrent une implication possible de pol Kappa au niveau des séquences répétées. Nous avons pu mettre en évidence une interaction entre pol Kappa et Cenpb, protéine centromérique reconnaissant une séquence de 17 paires de bases dans l'ADN a-satellite. Ces résultats préliminaires suggèrent que le rôle de pol Kappa dans le checkpoint de phase S s'adresse notamment aux régions d'hétérochromatine. L'ensemble des résultats obtenus montre l'importance de pol Kappa dans le maintien de la stabilité génomique, par son rôle dans le checkpoint de phase S, et par son implication dans la régulation de Chk1 en condition de stress réplicatif. / DNA replication is a major event for cells which allow the faithful duplication of genetic material. It is a critical step of cell cycle, because replication forks encounters frequently naturals barriers (non B-DNA structures), exogenous barriers (chemicals agents), or endogenous barriers (oxydatives lesions). These different barriers can be at the origin of chromosomes breaks and lead to genetic instability. To overcome the stalled forks, cells have evolved two major mechanisms: the induction of ATR replication checkpoint pathway and the recruitment of specialized DNA polymerase to perform the translesion synthesis. This two pathways are essential to maintain genomic stability. Human DNA polymerase Kappa (pol Kappa), the most conserved specialized DNA polymerase, is best known to participate to translesion synthesis. Recently, we have shown that pol kappa has a crucial role in the S-phase checkpoint activation. Indeed, pol Kappa is implicated in the synthesis of short DNA intermediates at the stalled forks, facilitating the recruitment of 9-1-1 clamp, and is required for an optimal phosphorylation of Chk1, the main effector of the S-phase checkpoint. Durant my PhD thesis, I explored the molecular mechanisms underlying this newly identified role. We have constructed several pol kappa mutants, and we have observed that for the mutation in the PCNA binding domain impeded pol kappa to form foci in response to replication stress. We also showed the requirement of this domain for pol Kappa recruitment on chromatin. By different experimental approaches, we have described a complex in which pol Kappa interacts with Rad9 and Chk1, two proteins required for the S-phase checkpoint activation. The Chk1 phosphorylation defect observed in absence of Kappa could also be the consequence of the Chk1 protein level decreased in the nucleus, meaning a potential common regulation between pol Kappa and Chk1. Based on this observation, we have studied how pol Kappa is regulated upon a replication stress and like Chk1, pol Kappa seems to be regulated by ubiquitination. We focused our attention on USP7 an ubiquitin hydrolase known to regulate Chk1. We have demonstrated an interaction between pol Kappa and USP7, which is stimulated after replication stress. Moreover, USP7 depletion leads to a decrease of pol Kappa level in the nucleus, suggesting that de-ubiquination of pol Kappa could to be a prerequisite for its checkpoint function and its stability.